- Interferon and lamivudine vs. interferon for hepatitis B e antigen-positive hepatitis B treatment: meta-analysis of randomized controlled trialsDan Rudin
Department of Internal Medicine, Staten Island University Hospital, Staten Island, NY 10305, USA
Liver Int 27:1185-93. 2007..To compare interferon monotherapy with its combination with lamivudine for hepatitis B e antigen (HBeAg)-positive hepatitis B treatment...
- Lamivudine and interferon versus lamivudine monotherapy for HBeAg-positive hepatitis B treatment: a meta-analysis of randomized, controlled trialsDan Rudin
Department of Internal Medicine, Staten Island University Hospital, Staten Island, New York 10305, USA
Adv Ther 24:784-95. 2007..In contrast, when conventional interferon-a is used, its combination with lamivudine should be considered...
- Somatostatin and gabexate for post-endoscopic retrograde cholangiopancreatography pancreatitis prevention: meta-analysis of randomized placebo-controlled trialsDan Rudin
Department of Internal Medicine, Staten Island University Hospital, 475 Seaview Avenue Staten Island, NY 10305, USA
J Gastroenterol Hepatol 22:977-83. 2007..Prior studies have suggested the efficacy of somatostatin and gabexate in post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis prevention. We examined this notion in our study...
- Somatostatin bolus injection for post-ERCP pancreatitis prevention: a need for further studyDan Rudin
Gastrointest Endosc 67:190; author reply 190-1. 2008